Why J&J Investors Aren't So Concerned About $4.69B Talc Verdict
Johnson & Johnson should ready itself for a flood of new lawsuits after a jury ordered the company to pay $4.69 billion to 22 women who blamed their ovarian cancer on asbestos in its talc products, legal experts said.
from Biotech News
0 Comments